Abicipar Pegol Completed Phase 2 Trials for Macular Degeneration Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03539549 | A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) | |
| NCT02181504 | A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration | |
| NCT02181517 | A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration |